American Heart Association

Patients should talk to doctors before changing dosage on anti-clotting drug

A recent report questions whether more could be done to prevent side-effects and improve effectiveness of the anti-clotting drug dabigatran, but medical experts urge people to continue taking the medication as prescribed unless their physician says otherwise.

The drug, sold under the brand name Pradaxa, is one of a relatively […]

Questions raised about managing dabigatran’s risks

Q. What did the British Medical Journal article say about dabigatran/Pradaxa and its manufacturer?

The journal released a report questioning whether drugmaker Boehringer-Ingelheim fully disclosed all it knew about how doctors could possibly lower the risk of bleeding side effects of Pradaxa by measuring blood levels or the anti-clotting effects […]